The Pharma Mini MBA

This 3-day accelerated management programme will provide you with practical management tools to apply in the workplace, as well as giving a real taste of an MBA course with pharma case studies from business schools.

5-7 Nov 2018

& 14-16 May 2019 , 4-6 Nov 2019

GBP 1,799
EUR 2,519
USD 2,806

Book now

Course Overview

A 3 day accelerated management programme, designed specifically for Pharmaceutical / Biotechnology professionals and also applicable Medical Device / Animal Health Industries, to give you the high- performance management skills of an MBA. This intensive course will help you to translate your learning into new behaviours and improvements in your capability and performance and will work through live issues impacting on the industry and on you directly. The individual and group exercises will focus on Bio/Pharmaceutical /Generic MBA case studies, and also on your own challenges and examples. The case studies will help also give the ‘feel’ of a full MBA and help you understand more about the strategies used in todays Pharmaceutical and associated industries.

Please note that there will also be some case study reading to do each evening (approximately 35 mins)

A residential rate to include 2 nights accommodation is also available when booking.

Why you should attend

Working in the highly competitive Bio / Pharmaceutical Industry, with ever-increasing change and pressure, is probably one of the most challenging managerial roles of any Industry today. This course has been especially designed to help you transcend these challenges by training you to become equipped to see the bigger picture in all aspects of your role. It will help you build your management skills for the future and prepare you to fulfill your ambitions.

The Pharma 3 day Mini MBA accelerated management programme is a distillation of the most valuable parts of an MBA, as applied to the Bio/Pharmaceutical industry. It will provide you with practical management tools to apply in the workplace, as well as giving a real taste of an MBA course with the Pharmaceutical case studies from business schools

The skills you will improve include:-

  • Problem solving
  • Strategic thinking
  • Seeing the bigger picture
  • Leadership
  • Decision making, priorisation
  • Commercial awareness
  • Change management
  • Implementing strategy
  • Team working
  • Environmental awareness
  • Project Management
  • Cross-cultural communication
  • Increased self confidence

Who should attend

A “must attend” for Professionals in the Bio / Pharmaceutical / Medical Device / Animal Health Industries wishing to develop their business management skills for more senior levels and beyond more technical skills. It will also help anyone thinking of studying for an MBA who would like an idea of what is involved. It is particularly beneficial to attend with a colleague to maximise the practical learning.

Programme Day One

09.00 Registration and coffee

09.30 Mini MBA Module 1

  • Strategic Thinking and Applying this in the Bio/Pharma Industry
  • What is strategic thinking and its importance in the bio/pharma industry?
  • Strategic analysis key tools
  • Understanding the competitive environment – using bio/pharma case studies
  • Applying the tools to your own context
  • More application of the tools – option grid
  • Obtaining the value out of strategy in the pharma industry
  • Portfolio management used in the bio/pharma industry

17.00 Close of day one

Programme Day Two

09.30 Mini MBA Module 2

  • Commercial Management and Leadership in the Bio/Pharma industry
  • Portfolio management used in the bio/pharma industry
  • Understanding business performance (pharma case study)
  • Diagnosing specific performance problem
  • Benefits, costs of doing an MBA and the different routes
  • The role of leadership
    • What are the core competences of effective leaders?
    • Leadership vs. management
    • Leadership style
  • Hot Topics in Market Access

17.00 Close of day two

Programme Day Three

09.30 Mini MBA Module 3

Leading Change and Project Management in the Bio/Pharma Industry

  • Leading successful change
    • Diagnosis around change
    • How to create the conditions for successful change
    • Why people resist change and how to manage this
    • Change management (pharma case study in leading a structural reorganisation)
    • Creating a team, department and organisation relevant to today’s pharmaceutical business needs
    • Team formation and development
  • Essentials of managing projects
    • Project management tools and techniques to use in implementing pharmaceutical projects
    • Applying key project management techniques to pharmaceutical projects
    • How to manage in a matrix management environment
    • Understanding of cultural awareness to work more effectively with pharmaceutical colleagues

Managing Innovation in the Pharmaceutical Industry

MINI MODULEPOST COURSE DEVELOPMENT
Practical application / review

  • Personal development Action Plan to apply the learning within your own organisation
  • Revisiting your competency assessment – what has shifted
  • Recommended further reading
  • Practical application of tools (toolkit)

16.30 Close of day three

Presenters

Laura Brown (5-7 Nov 2018, 14-16 May 2019)

Dr Laura Brown MBA, BSc,PhD, is a Pharmaceutical QA and Training Consultant, Course Director for the MSc in Clinical Research, School of Pharmacy at the University of Cardiff. She has more than 20 years’ experience of quality assurance in the pharmaceutical industry and has worked for several companies, including GSKs Hoechst Marion Roussel, Farmitalia and Phoenix International. She has a particular expertise in quality assurance including risked based approaches to quality systems, data Integrity and project management in the pharmaceutical industry. She regularly writes on pharmaceutical regulatory issues including “The Planning of International Drug Development”, in the Clinical Research Manual, Euromed and the “Impact of Brexit”, RQA Journal 2017.

Leela Barham (5-7 Nov 2018)

BSc (Economics), MSc (Health Economics)

Leela Barham is an independent health economist and policy expert working on a freelance basis. This follows 7 years at a specialist economic consulting firm working in a small dedicated health and pharmaceutical team.
She has more than 10 years experience in the pharmaceutical industry – both at home and abroad – and has worked for all stakeholders in the health care system ranging from patient organisations, the National Health Service, health insurers, and the pharmaceutical industry.
She has particular expertise in public and patient involvement, Patient Access Schemes/risk sharing schemes, the Cancer Drugs Fund, policy on Health Technology Assessment (HTA), and the Pharmaceutical Price Regulation Scheme (PPRS). She regularly writes on hot topics affecting the industry for Pharmaceutical Executive, Pharmaphorum and EyeforPharma and has also written for PharmaTimes, and Pharma Pricing and Reimbursement. She has also had her research published in peer review journals including The Patient and Pharmacoeconomics.

Nick Meadows (5-7 Nov 2018)

Nick Meadows has nearly 10 years of experience working in the life sciences industry as a management consultant, technology transfer analyst and medical research scientist. In 2016 he joined Strategy& (part of the PwC network) where he is supporting clients within the pharmaceutical industry address strategic and operational challenges in development and commercial functions. As a consultant he has managed engagements across research and development and commercial functions of the life sciences and pharmaceutical industry. In the past 5 years his work has spanned major transformational projects in clinical operations and research and development, to asset level strategy through direct engagement with program teams and commercial leads. In his former role at Kinapse (2011 – 2016) he led the market access service line where he supported clients optimise pricing and reimbursement outcomes for launching and development products. In addition he has collaborated with regulators, policy makers and healthcare practitioners to provide recommendations to accelerate the development of personalised medicines. He has also developed a deep understanding of the biosimilars landscape.
He holds an MBA from Saïd Business School, University of Oxford, and a PhD and BSc (Hons) in Molecular Biology from University of Queensland, Brisbane, Australia.

Book now

5-7 Nov 2018
5-7 Nov 2018 Rembrandt Hotel, London GBP 1,799.00
EUR 2,519.00
USD 2,806.00
+ VAT @ 20.00%
Enrol now
14-16 May 2019
14-16 May 2019 Rembrandt Hotel, London GBP 1,799.00
EUR 2,519.00
USD 2,806.00
+ VAT @ 20.00%
Enrol now
4-6 Nov 2019
4-6 Nov 2019 Venue not yet confirmed
+ VAT @ 20.00%
Enrol now

You may also be interested in

Previous customers include...

  • Abbott Healthcare Products BV
  • AbbVie
  • Albumedix Ltd
  • BAUSCH & LOMB INC
  • Bayer AG
  • Coloplast A/S
  • Core Informatics
  • Dako Denmark A/S
  • Ferring Pharmaceuticals A/S
  • GALDERMA R & D
  • GEOPHARMA LIMITED
  • GW {harmaceuticals
  • Ipsen Pharma SAS
  • Laboratoires Fournier SA
  • Merial Norden A/S
  • Novo Nordisk
  • Owen Mumford
  • PHYTOPHARM KLEKA SA
  • Polpharma SA
  • Pronova BioPharma
  • Quotient Clinical Ltd
  • Sanofi-Aventis
  • Sanquin Plasma Products
  • Shire Pharmaceutical Ltd
  • SI Associates Ltd
  • UCB Pharma SA
  • Vantia Limited
  • Veryan Medical Limited
  • Vifor Pharma AG
  • ZAMBON SPA

Laura is a very dynamic person that knows very well how to deliver a message. The topics are very interesting from the pharma/management point of view and articulated
- Would be interesting to have topic about pharma at geographical level

Janneth Ospina Paladines, Senior Regulatory Affairs Associate, Gilead Sciences International

I am very satisfied with the course (including the speakers, Laura Brown is excellent), I think it gave a real good flavour of an MBA.

Monika Elfström, Regulatory Affairs Labelling Manager, Vifor Pharma AG

Very interesting

Emine Akin, Marketing & Sales Junior Assistant, Chiesi Group

Really good overview and opportunity to ask many questions. Great course.

Luisa Teixeira, Account Manager, Owen Mumford Ltd

Overall good, too little time!

Janni Hermansen, Senior PV Advisor, LEO Pharma

I found it really practical, lively with possibility to exchange experiences

Mireille Pierrevelcin, Export Area Manager, Cesra Arzneimittel GmbH & Co

The course is very good. Gives you in three days an overall view on core subjects that management people need to know to improve. Case studies were excellent and realistic. Speakers were great

Diana Binkert, , Acino International AG

Course was very condensed either reduce the content or extend the course days

Aziz-ul-Islam Chaudhry, Head of Regulatory Affairs, Martindale Pharma

Overall excellent course, very well organized. Suitable content, stimulating presentations and excellent speakers.

Suna Horner, Associate Medical Manager, HRA Pharma UK & Ireland Ltd

It exceeded my expectations. Really enjoyed practical sessions and focused environment.

Andriy Kirmach, Associate Director, International Compliance & Ethics, Allergan

It was a very nice overview on MBA topics overview on MBA topics with a great speaker and interesting discussions

Ricarda Tiemeyer, Drug Safety Scientist & Deputy LSR, Roche Pharma (Switzerland) AG

Excellent. Thoroughly enjoyed it and left feeling like I had learnt something, which, at the end of the day, is the primary goal. I appreciated the method of teaching and enjoyed meeting other people on the course.

Zain Masters, Business Development & Licensing Director, Masters Speciality Pharma

Provided exactly what I required

Peter Gaines, Chief Medical Officer, Veryan Medical Limited

Few topics to develop

Edmondo Corona, Plan Engineering Director, AbbVie

This was a well-organised course and both the content and speakers were very good. I do think that the topics could have been tied together better in some instances in the same way as the strategy tools we covered. Some elements such as project management were covered far too quickly to be of any use.

Emma Woods, Pharmaceutical Development Innovation Lead, AstraZeneca Pharmaceuticals Development

Perfect blend of theory and practicality that allowed the attendees to process and apply the information to real world scenarios. Extremely valuable taster into the world and benefits of an MBA!

Dave Wood, Account Director, PharmiWeb Solutions

An excellent course. I would recommend to all wanting a flavour of an MBA.

Bindu Patel, Senior Manager , Sanofi Pasteur MSD

It was rushed in places with things being skipped over - its good to try and include a lot but not if its skipped...doesn't help

GEOF WOLFENDEN, IP & Contracts Manager, AstraZeneca

It was very informative and engaging with real potential to help with daily practicalities. The full content and delivery is hitting the mark in my opinion.

Irem Bostanci, Account Manager OEM, Owen Mumford Ltd

Good

Kevin Polhill, Quality and Regulatory Compliance Specialist, Invicta Compliance

Excellent trainer, lots of info in a short time but actually by the end I thought it was a suitable duration and speed. Would have been nicer to have a little more on the PM part at the end simply because that fits better with my role.

Julia Caldwell, Clinical Trial Manager, Allergan

Good mix of people and perspectives; venue was easy to get to. Guest speakers were a good idea.

Julie-Anne Webb, Inside Sales Associate - EU, Core Informatics